NP+PA Perspectives in Dermatology | JCAD | The Journal of Clinical and Aesthetic Dermatology

Full Digital Editions:

NP+PA Perspectives in Dermatology: March–April 2024

NP+PA Perspectives in Dermatology: January-February 2024

NP+PA Perspectives in Dermatology: December 2023

Current Issue: Featured Articles

Psychodermatology in the Era of COVID-19

J Clin Aesthet Dermatol. 2021;3(3 Suppl 1):S24–S27 by Bárbara Roque Ferreira, MD; Mohammad Jafferany, MD;and Laurent Misery, MD, PhD Dr. Ferreira is with the University of Brest, Laboratoire Interactions...

Editorial Message from Guest Editor Francesca Wolfe, MPAS, PA-C

Francesca Wolfe, MPAS, PA-C, is a physician assistant at Pennsylvania Dermatology Group and clinical instructor at Thomas Jefferson University Physician Assistant program in Philadelphia, Pennsylvania. Dear...

Updates from the Society of Dermatology Physician Assistants (SDPA): Professional Medical Societies—How Important Is that Membership?

by the SDPA Board of Directors Are you a committed healthcare practitioner who loves serving the public? Of course you are! You wouldn’t have spent a large part of your life pursuing an advanced provider...

Serum Zinc and Inflammatory Cytokines in Vitiligo

by Eman Mostafa Sanad, MD; Asmaa Adel El-fallah, MD; Ahmed Raad Al-doori, Msc; and Rehab Mohammed Salem, MD Dr. Sanad is Professor of Dermatology and Andrology, Faculty of Medicine, at Benha University...

Spotlight Interview: featuring Francesca Wolfe, MPAS, PA-C

Francesca Wolfe, MPAS, PA-C, earned her Masters degree in Physician Assistant Studies from Thomas Jefferson University in Philadelphia, Pennsylvania. She furthered her training by completing a dermatology...

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next

Trending on JCAD TV

TJ Chao, PA-C: Utilizing Topical Treatments for Patients with Atopic Dermatitis

Atopic Dermatitis Advisor Audio Series:

Incorporating Topical and Oral Treatments into Practice

Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.